131 FRAIL-AF RANDOMISED CONTROLLED TRIAL: RESULTS Switch to NOAC Male 81.4 4 75 88 Oropharyngeal NOAC Switch to NOAC Male 78.4 3 88 147 Brain NOAC Switch to NOAC Male 75.8 7 63 39 Urogenital NOAC Switch to NOAC Male 84.6 4 57 182 Skin NOAC Switch to NOAC Female 83.8 6 78 245 Brain NOAC Switch to NOAC Male 79.9 3 49 164 Urogenital NOAC Switch to NOAC Male 75.9 8 70 188 Gastrointestinal NOAC Switch to NOAC Male 78.1 4 84 101 Oropharyngeal NOAC Switch to NOAC Female 81.1 6 57 122 Skin NOAC Switch to NOAC Male 79.1 3 88 176 Brain NOAC Switch to NOAC Male 79.3 4 51 314 Urogenital NOAC Switch to NOAC Male 75.5 4 55 114 Gastrointestinal NOAC Switch to NOAC Male 75.4 3 78 106 Skin NOAC Switch to NOAC Female 75.5 3 87 58 Oropharyngeal NOAC Switch to NOAC Female 89.7 4 70 41 Oropharyngeal NOAC Switch to NOAC Female 76.7 3 51 84 Musculoskeletal NOAC Switch to NOAC Male 80.8 4 62 183 Skin NOAC Switch to NOAC Male 86.9 3 64 204 Urogenital NOAC Switch to NOAC Female 81.0 4 57 184 Skin NOAC Switch to NOAC Male 85.1 5 71 169 Other NOAC Switch to NOAC Male 83.2 3 48 190 Gastrointestinal NOAC Switch to NOAC Male 82.3 4 46 333 Ophthalmic NOAC Switch to NOAC Male 90.3 6 71 286 Urogenital NOAC Switch to NOAC Male 79.5 3 72 360 Gastrointestinal NOAC Switch to NOAC Male 86.6 4 70 217 Ophthalmic NOAC Switch to NOAC Male 86.2 6 67 298 Other NOAC 7
RkJQdWJsaXNoZXIy MTk4NDMw